APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD. - Wikidata - awgldk - TriplyDB

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

http://www.wikidata.org/entity/Q33690208

about

Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment The BDNF Val66Met polymorphism moderates the relationship between cognitive reserve and executive function Identification of Differentially Expressed Genes through Integrated Study of Alzheimer's Disease Affected Brain Regions The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset.The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function.Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.Patterns of progressive atrophy vary with age in Alzheimer's disease patients.Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ɛ4 genotype.Potential Role of OERP as Early Marker of Mild Cognitive Impairment Neuroimaging genetic risk for Alzheimer's disease in preclinical individuals: From candidate genes to polygenic approaches Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease Correction: APOE ε4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD Are the effects ofAPOEϵ4 on cognitive function in nonclinical populations age- and gender-dependent?

P2860

Q26744866-31329DC1-1F1C-430E-8ACC-21B1A4064CAC Q30981669-7F9A538B-5217-429A-9286-72892C4370F7 Q33834758-F556AE2A-EBDD-4FC4-B1FE-D7EC91D99E9F Q35813169-9DC8D378-0026-458E-B4BC-5876F4759907 Q35981049-4E481A91-2114-4C88-A923-244E2BFD78AE Q36075642-6A72E601-A211-45AA-BAF6-85F4A4F98043 Q36202834-CE43DFC4-1E5C-49B1-9433-54CC27879F44 Q36217479-A762A3EA-DC4E-47AD-9644-ABA72B1BF008 Q36942402-BEC39A64-E17B-4342-B401-F642963BC202 Q37664085-DEED007C-509D-44B9-8CD3-F5FF8C13AC2C Q39873829-467A953B-A47B-4819-86B7-787FCA6183B1 Q41538249-274F19DF-3220-4BFE-BBC8-BA576D09EA50 Q47342494-CCD4A72E-D840-4FFD-89FC-1955BFA359F9 Q53035410-AF699D0E-97E1-4C7F-BC34-EDFBF367B15E Q53397288-7C69A640-040E-485C-ADB9-053D6100A2DA Q57075079-B7D6AB3A-52A2-4FE9-BDC1-E02517266A0F Q57513294-9325E030-8274-44F6-855D-AEEDA683F1C1 Q57816569-31D79393-C85A-4562-8FE4-7679FB1F4CE8 Q57911807-3AFB7925-EDC1-4376-BE76-DD8C84CBFB8A Q59050338-A6526FD0-898C-45E1-92F7-AF40F9224335

P2860

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

http://www.wikidata.org/entity/Q33690208

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

@ast

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

@en

type

label

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

@ast

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

@en

prefLabel

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

@ast

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

@en

P1433

Q33690208-76615B39-B40C-42C6-8F18-E916A0397CE4

P1476

Q33690208-CEF802DA-7271-4B00-99FD-3AEA19486429

P2093

Q33690208-1E1BFAAF-4968-4C6B-A384-910F5ACB4077

Q33690208-36035276-DCF3-4C06-A1F3-ACAD22777B69

Q33690208-360B5CB4-7067-426C-B50D-4A6B2B9874FB

Q33690208-797717CE-0DE4-4875-8C43-84E94A4C018D

P2860

Q33690208-082B6AE4-3ABA-4E21-B792-9D4B1AB9BB28

Q33690208-09B3F5B4-85F8-4649-9B02-112D30BD01D5

Q33690208-0CBD138A-546B-4258-BAEB-BC406E4F40E8

Q33690208-1B703410-2A26-4BFD-9BC7-41C083B174DD

Q33690208-2B87B9D1-4B65-4793-9111-570F152DBBCA

Q33690208-32559335-0706-4FF9-A6FE-7D03FFDFD677

Q33690208-3B05EA50-BA05-4F4D-AB9D-3C56F7919151

Q33690208-3DDCC33D-A224-4033-86E4-451B51BD2105

Q33690208-46B5BB36-60FD-4EFB-AECC-D3BEB9A3D1EE

Q33690208-5A1313A1-E6FB-4350-82A0-90AB4A979474

P304

Q33690208-696A318F-6A00-46FC-8F38-41A1FF8EB608

P31

Q33690208-6281BAB1-59CA-43B4-BFC5-F2C7DAE68DFD

P356

Q33690208-4CEA8B33-1E6E-4E69-B543-C4D51A2C47FB

P407

Q33690208-C0FBE11C-C073-4351-9F52-44F5701115E0

P433

Q33690208-1F8CF93A-9436-4B9D-A294-7B6DA292E305

P478

Q33690208-8E931093-40E0-4B65-AE7B-AEDF62ECD22B

P50

Q33690208-076B5BBA-5BFC-435C-BEDF-25A04C3B2712

Q33690208-A9FEA61E-267C-42BD-841C-4E60A78DC26B

Q33690208-B04B6B12-9B04-4E97-BE12-D04931808D5F

Q33690208-BD91978C-3BD2-4976-9728-B87C123E77A1

Q33690208-C18179E6-D52B-4076-8FE2-0C83EC1D0C16

Q33690208-DD1A2F3B-CB7C-485A-9D36-F63B9683A28F

P577

Q33690208-741143ED-CA70-461F-B6B2-FD49B89A06C8

P5875

Q33690208-B278E0DD-E510-4948-AEE6-5D97AE9C363F

P698

Q33690208-EECBDF33-3764-4AD9-9149-41B3B8A94F97

P932

Q33690208-E5ED7E44-ABB0-478D-91E2-E31575CA80CA

P356

JOURNAL.PONE.0097608

P1433

P1476

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

@en

P2093

Alzheimer's Disease NeuroImaging Initiative

http://www.w3.org/2001/XMLSchema#string

Emily N Manning

http://www.w3.org/2001/XMLSchema#string

Kelvin K Leung

http://www.w3.org/2001/XMLSchema#string

Nick C Fox

http://www.w3.org/2001/XMLSchema#string

P2860

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history

Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study

Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data.

A nonparametric method for automatic correction of intensity nonuniformity in MRI data.

Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.

Brain MAPS: an automated, accurate and robust brain extraction technique using a template library

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

P304

e97608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0097608

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan Bartlett

Josephine Barnes

Sebastien Ourselin

P577

2014-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263040937

http://www.w3.org/2001/XMLSchema#string

P698

24878738

http://www.w3.org/2001/XMLSchema#string

P932

4039513

http://www.w3.org/2001/XMLSchema#string